(Q39088146)
Statements
1 reference
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab (English)
1 reference
Maitreyee Hazarika
1 reference
Meredith K Chuk
1 reference
Marc R Theoret
1 reference
Sirisha Mushti
1 reference
Kun He
1 reference
Shawna L Weis
1 reference
Alexander H Putman
1 reference
Whitney S Helms
1 reference
Xianhua Cao
1 reference
Hongshan Li
1 reference
Hong Zhao
1 reference
Liang Zhao
1 reference
Joel Welch
1 reference
Laurie Graham
1 reference
Meredith Libeg
1 reference
Rajeshwari Sridhara
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
13 January 2017
1 reference
1 reference
23
1 reference
14
1 reference
3484-3488
1 reference
Identifiers
1 reference
1 reference